chr14-104929380-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_138790.5(PLD4):c.542C>T(p.Pro181Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00005 in 1,560,876 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000052 ( 0 hom. )
Consequence
PLD4
NM_138790.5 missense
NM_138790.5 missense
Scores
2
4
13
Clinical Significance
Conservation
PhyloP100: 0.680
Genes affected
PLD4 (HGNC:23792): (phospholipase D family member 4) Predicted to enable single-stranded DNA 5'-3' exodeoxyribonuclease activity. Predicted to be involved in hematopoietic progenitor cell differentiation; phagocytosis; and regulation of cytokine production involved in inflammatory response. Predicted to be located in early endosome and endoplasmic reticulum membrane. Predicted to be active in several cellular components, including endoplasmic reticulum; phagocytic vesicle; and trans-Golgi network membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.13166761).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PLD4 | NM_138790.5 | c.542C>T | p.Pro181Leu | missense_variant | 5/11 | ENST00000392593.9 | |
PLD4 | NM_001308174.2 | c.563C>T | p.Pro188Leu | missense_variant | 5/11 | ||
PLD4 | XM_011536411.3 | c.563C>T | p.Pro188Leu | missense_variant | 5/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PLD4 | ENST00000392593.9 | c.542C>T | p.Pro181Leu | missense_variant | 5/11 | 1 | NM_138790.5 | P2 | |
PLD4 | ENST00000540372.5 | c.563C>T | p.Pro188Leu | missense_variant | 5/11 | 2 | A2 | ||
PLD4 | ENST00000649344.1 | c.542C>T | p.Pro181Leu | missense_variant | 5/11 | ||||
PLD4 | ENST00000557573.1 | c.536C>T | p.Pro179Leu | missense_variant | 5/7 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152120Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
5
AN:
152120
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000301 AC: 5AN: 166248Hom.: 0 AF XY: 0.0000224 AC XY: 2AN XY: 89116
GnomAD3 exomes
AF:
AC:
5
AN:
166248
Hom.:
AF XY:
AC XY:
2
AN XY:
89116
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000518 AC: 73AN: 1408756Hom.: 0 Cov.: 31 AF XY: 0.0000532 AC XY: 37AN XY: 695908
GnomAD4 exome
AF:
AC:
73
AN:
1408756
Hom.:
Cov.:
31
AF XY:
AC XY:
37
AN XY:
695908
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152120Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74302
GnomAD4 genome
AF:
AC:
5
AN:
152120
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
74302
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2023 | The c.542C>T (p.P181L) alteration is located in exon 5 (coding exon 4) of the PLD4 gene. This alteration results from a C to T substitution at nucleotide position 542, causing the proline (P) at amino acid position 181 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
.;.;M;.
MutationTaster
Benign
N;N
PrimateAI
Benign
T
PROVEAN
Pathogenic
.;D;D;D
REVEL
Benign
Sift
Uncertain
.;D;D;D
Sift4G
Uncertain
.;D;D;D
Polyphen
0.99, 0.98
.;D;D;.
Vest4
0.34, 0.34
MutPred
0.43
.;Loss of glycosylation at T185 (P = 0.0309);.;.;
MVP
0.37
MPC
0.42
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at